During the past decade, Ivey Eye Institute conducted 19 clinical trials. In the 10-year time frame, 19 clinical trials started and 6 clinical trials were completed, i.e. on average, 31.6% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 5 clinical trials were completed. i.e. 71.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Ivey Eye Institute" #1 sponsor was "Lawson Health Research Institute" with 13 trials, followed by "Hoffmann-La Roche" with 4 trials sponsored, "Allergan" with 2 trials sponsored, "Apellis Pharmaceuticals, Inc." with 2 trials sponsored and "Lux Biosciences, Inc." with 2 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Ivey Eye Institute" #1 collaborator was "Pfizer" with 2 trials as a collaborator, "Canadian National Institute for the Blind" with 1 trials as a collaborator, "Canadian Retinal Trials Group" with 1 trials as a collaborator, "Ivey Eye Institute" with 1 trials as a collaborator and "Novartis Pharmaceuticals" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "Ivey Eye Institute" are "Diabetic Macular Edema" (4 trials), "Anxiety" (3 trials), "Depression" (3 trials), "Quality of Life" (3 trials) and "Age Related Macular Degeneration" (2 trials). Many other conditions were trialed in "Ivey Eye Institute" in a lesser frequency.

Most popular intervention types in "Ivey Eye Institute" are "Drug" (21 trials), "Other" (10 trials), "Procedure" (3 trials), "Behavioral" (1 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Sham Procedure" (6 trials), "Faricimab" (4 trials), "Aflibercept" (3 trials), "Placebo" (3 trials) and "Treatment as Usual" (3 trials). Other intervention names were less common.

The vast majority of trials in "Ivey Eye Institute" are 30 trials for "All" genders.

Currently, there are NaN active trials in "Ivey Eye Institute". 1 are not yet recruiting, undefined are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 16 completed trials in Ivey Eye Institute, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Ivey Eye Institute, 1 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 10 trials that are defined as “Not Applicable".